Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
CAR-TCR Global 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
CAR-T
2:49
Exciting advances in CAR-T and TCR research
David Gilham
• 22 Feb 2021
2:38
DARIC33 CAR T-cells in AML
Jacob Appelbaum
• 12 May 2021
2:55
Identifying early predictors of neurotoxicity following CAR-T infusion
Jaap Boelens
• 26 May 2021
2:56
Allogenic NKX101 in r/r AML
James Trager
• 22 Feb 2021
3:07
Horizon scanning in anti-CD19 CAR T-cell therapy
Marco Alessandrini
• 20 May 2021
1:40
DARIC33: CAR T with an on/off switch
Jacob Appelbaum
• 12 May 2021
1:50
What to expect at ISCT 2021
Bruce Levine
• 11 Mar 2021
6:34
Combining iNKT and CAR technology
Marc van Dijk
• 23 Feb 2021
3:23
How the TCR field can learn from CARs
Dolores Schendel
• 25 Feb 2021
3:05
Targetting cancer with allogeneic NK cell therapies
James Trager
• 10 Mar 2021
2:09
CAR-NKs for B cell malignancies
James Trager
• 10 Mar 2021
4:15
CT053, anti-GPC3 CAR-T and targeting solid tumors
Hong Ma
• 19 Feb 2021
3:24
CYAD-101 & alloSHRINK: allogeneic CAR-T cell therapy in MSS mCRC
David Gilham
• 22 Feb 2021
3:28
Analysing trends in the CAR-TCR landscape
Vasiliki Zochiou
• 22 Feb 2021
2:29
CYCLE-1: next generation NKG2D-based CAR T-cells in AML/MDS
David Gilham
• 22 Feb 2021
1:48
CAR-TCR Europe highlights: synthetic biology & the autologous vs allogeneic debate
Dalip Sethi
• 23 Feb 2021
1
2
3
4
5
6
Next